News and Announcements
Final opportunity before official app launch
- Published August 26, 2022 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
After almost 5 years, the Cashero project is now just days away from its global launch that will make it available to individuals, businesses, and charities in over 100 countries worldwide.
What is Cashero’s story so far?
The Cashero project was conceptualised 4 years ago to resolve the issues of low-interest rates and high payment friction faced by consumers saving and remitting funds across the Globe.
Cashero has received support from over 250 investors to date.
The Technology development is now complete and Marketing tests conducted by the same teams that catered for Monzo and Revolut were completed in January 2022 following 17 months of tests and research.
The team is currently scaling the technical and support teams and the Founding partners are speaking with strategic partners and investors ahead of the aggressive launch booked for September this year.
What is the plan for Cashero once launched
- Aggressive Online & Digital marketing with world-leading teams like Ladder, HVSEO, Global UK
- Aggressive White Label Agency and Ambassador agreements run on a revenue share model
- Strategic Partnerships and Acquisitions to catalyse expansion in over 120 Territories
How much is Cashero looking to raise?
The £4.35m Pre Launch Round ends 31st August.
Anticipated Returns and Forecasts for Investors?
40-60% on Launch
200 – 500% Return by Month 12 from Launch
500 – 800% Return by Month 24 from Launch
1200 – 1800% Return by Month 36 from Launch
Company Updates
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Dying for a Cure: Why Astraea is Stress-Testing the Future of Space Medicine
Astraea Technologies is solving a critical “blind spot” in the $1.5T space economy. Co-founders Brooke Mills and Gordon Carroll discuss their $5M seed raise, the HIRO-LAB platform, and their upcoming 2028 mission to the Moon to validate life-saving medicine in extreme environments.
Beyond the Drip: Elemental IV’s Infrastructure Play for a Fragile Supply Chain
In the high-stakes world of life sciences, we often hunt for the next “miracle molecule” or gene-editing breakthrough. But Storme Paes, Founder and Commercial Director of Elemental IV, found her mission in something far more fundamental, yet dangerously overlooked: a simple bag of saltwater. The “Meeting Room” Revelation The genesis of Elemental IV didn’t occur […]
Backed By Leading Investment Groups and Family Offices
